analyst
PC
NASDAQ · PCRX
Pacira BioSciences, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$24.91
Up+$0.83 (+3.45%)
Updated Sep 17, 2026, 3:12 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.17B
- P/E ratio
- 38.27
- Dividend yield
- 0.00%
- 52-week range
- $21.16 – $27.66
- Volume
- 759.13K
- Avg. volume
- 635.91K
Price performance
PCRX price history
1M range · 20 trading sessions · Daily adjusted prices
PCRX closed at $24.91 after 20 trading sessions, up 2.26% for the selected period.
- Last close
- $24.91
- Period change
- +2.26%
- Period low
- $23.83
- Period high
- $26.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $24.06 | $24.91 | $24.06 | $24.91 | 759.13K |
| Sep 15, 2026 | $24.63 | $24.94 | $23.65 | $24.08 | 824.51K |
| Sep 14, 2026 | $25.71 | $25.99 | $24.65 | $24.68 | 418.44K |
| Sep 11, 2026 | $25.43 | $25.57 | $25.18 | $25.36 | 538.04K |
| Sep 10, 2026 | $25.92 | $25.995 | $25.10 | $25.16 | 733.77K |
| Sep 9, 2026 | $25.62 | $25.88 | $25.13 | $25.88 | 571.74K |
| Sep 8, 2026 | $25.98 | $26.41 | $25.675 | $25.87 | 386.42K |
| Sep 4, 2026 | $26.38 | $26.65 | $26.31 | $26.35 | 481.69K |
| Sep 3, 2026 | $26.74 | $26.84 | $26.32 | $26.60 | 598.52K |
| Sep 2, 2026 | $26.52 | $26.91 | $26.24 | $26.58 | 610.79K |
| Sep 1, 2026 | $26.01 | $26.50 | $25.975 | $26.47 | 729.46K |
| Aug 31, 2026 | $25.75 | $26.07 | $25.455 | $25.90 | 380.51K |
| Aug 28, 2026 | $25.74 | $26.045 | $25.555 | $25.76 | 483.55K |
| Aug 27, 2026 | $25.63 | $26.031 | $25.36 | $25.83 | 413.4K |
| Aug 26, 2026 | $25.46 | $26.025 | $25.315 | $25.90 | 506.09K |
| Aug 25, 2026 | $24.89 | $25.585 | $24.795 | $25.53 | 379.71K |
| Aug 24, 2026 | $24.60 | $25.04 | $24.49 | $24.86 | 336.67K |
| Aug 21, 2026 | $23.91 | $24.72 | $23.66 | $24.67 | 475.87K |
| Aug 20, 2026 | $24.11 | $24.405 | $23.72 | $23.83 | 402.8K |
| Aug 19, 2026 | $24.04 | $24.58 | $24.04 | $24.36 | 336.18K |
Latest PCRX news
The latest Smart Investors Daily articles mentioning PCRX.
Stock researchCompany · Financials
Loading stock research…